Dashboard
Manage Tickers

CSBR CHAMPIONS ONCOLOGY, INC.

Nasdaq championsoncology.com


$ 6.50 $ -0.07 (-1.11 %)    

Friday, 17-Oct-2025 15:59:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 6.487
$ 6.50
$ 5.88 x 1
$ 6.90 x 150
$ 6.37 - $ 6.50
$ 3.75 - $ 11.99
11,060
na
89.45M
$ 0.49
$ 30.30
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-15-2025 07-31-2025 10-Q
2 07-23-2025 04-30-2025 10-K
3 03-17-2025 01-31-2025 10-Q
4 12-16-2024 10-31-2024 10-Q
5 09-13-2024 07-31-2024 10-Q
6 07-19-2024 04-30-2024 10-K
7 03-14-2024 01-31-2024 10-Q
8 12-13-2023 10-31-2023 10-Q
9 09-13-2023 07-31-2023 10-Q
10 07-24-2023 04-30-2023 10-K
11 03-16-2023 01-31-2023 10-Q
12 12-13-2022 10-31-2022 10-Q
13 09-12-2022 07-31-2022 10-Q
14 07-22-2022 04-30-2022 10-K
15 03-15-2022 01-31-2022 10-Q
16 12-13-2021 10-31-2021 10-Q
17 09-13-2021 07-31-2021 10-Q
18 07-26-2021 04-30-2021 10-K
19 03-15-2021 01-31-2021 10-Q
20 12-14-2020 10-31-2020 10-Q
21 09-14-2020 07-31-2020 10-Q
22 07-28-2020 04-30-2020 10-K
23 03-16-2020 01-31-2020 10-Q
24 12-16-2019 10-31-2019 10-Q
25 09-16-2019 07-31-2019 10-Q
26 07-29-2019 04-30-2019 10-K
27 03-18-2019 01-31-2019 10-Q
28 12-17-2018 10-31-2018 10-Q
29 09-14-2018 07-31-2018 10-Q
30 07-30-2018 04-30-2018 10-K
31 03-19-2018 01-31-2018 10-Q
32 12-15-2017 10-31-2017 10-Q
33 09-14-2017 07-31-2017 10-Q
34 07-28-2017 04-30-2017 10-K
35 03-17-2017 01-31-2017 10-Q
36 12-14-2016 10-31-2016 10-Q
37 09-14-2016 07-31-2016 10-Q
38 07-29-2016 04-30-2016 10-K
39 03-16-2016 01-31-2016 10-Q
40 12-15-2015 10-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

champions-oncology-q1-adj-eps-002-beats-001-estimate-sales-13995m-beat-13513m-estimate
Champions Oncology Q1 Adj. EPS $0.02 Beats...
09/15/2025 19:56:49

Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(...

Core News & Articles
Earnings Scheduled For September 15, 2025
09/15/2025 08:32:09

insights-ahead-champions-oncologys-quarterly-earnings
Insights Ahead: Champions Oncology's Quart...
09/12/2025 14:01:47

4-biotech-stocks-that-are-showing-weakness-momentum-scores-fading-over-the-past-week
4 Biotech Stocks That Are Showing Weakness...
09/03/2025 10:21:00

Several biotech stocks have seen their strength fade over the past week, with their Momentum scores in Benzinga's Edge Stoc...

champions-oncology-q4-adj-eps-007-beats-020-estimate-sales-12355m-beat-12013m-estimate
Champions Oncology Q4 Adj. EPS $(0.07) Bea...
07/23/2025 20:01:09

Champions Oncology (NASDAQ:CSBR) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(...

Core News & Articles
Earnings Scheduled For July 23, 2025
07/23/2025 08:32:26

champions-oncology-appoints-rob-brainin-as-ceo-effective-aug-25
Champions Oncology Appoints Rob Brainin As...
07/18/2025 12:31:11

champions-oncology-granted-license-to-use-radioactive-materials-in-preclinical-studies
Champions Oncology Granted License To Use ...
04/28/2025 13:47:33

Champions Oncology (NASDAQ:CSBR), a leader in translational oncology research, has been granted a license to use radioactive ma...

craig-hallum-maintains-buy-on-champions-oncology-raises-price-target-to-12
Craig-Hallum Maintains Buy on Champions On...
03/12/2025 14:09:49

Craig-Hallum analyst Matt Hewitt maintains Champions Oncology (NASDAQ:CSBR) with a Buy and raises the price target from $8 t...

correction-champions-oncology-q3-adj-eps-036-beats-030-estimate-sales-1704m-up-from-1202m-yoy
CORRECTION: Champions Oncology Q3 Adj. EPS...
03/11/2025 20:01:06

earnings-scheduled-for-march-11-2025
Earnings Scheduled For March 11, 2025
03/11/2025 08:32:14

champions-oncology-announces-17-abstracts-accepted-for-aacr-2025-highlighting-in-vivo-and-organoid-platforms-ai-driven-models-and-multi-omics-dataset-for-oncology-research
Champions Oncology Announces 17 Abstracts ...
02/18/2025 14:06:13

why-imac-holdings-shares-are-trading-higher-by-over-108-here-are-20-stocks-moving-premarket
Why IMAC Holdings Shares Are Trading Highe...
01/28/2025 10:06:08

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
01/17/2025 12:05:43

craig-hallum-maintains-buy-on-champions-oncology-raises-price-target-to-8
Craig-Hallum Maintains Buy on Champions On...
12/12/2024 16:23:27

Craig-Hallum analyst Matt Hewitt maintains Champions Oncology (NASDAQ:CSBR) with a Buy and raises the price target from $6 t...

recap-champions-oncology-q2-earnings
Recap: Champions Oncology Q2 Earnings
12/11/2024 21:15:08

champions-oncology-q2-adj-eps-005-up-from-015-yoy-sales-135m-up-from-116m-yoy
Champions Oncology Q2 Adj EPS $0.05 Up Fro...
12/11/2024 21:06:50

zz

earnings-scheduled-for-december-11-2024
Earnings Scheduled For December 11, 2024
12/11/2024 08:32:07

a-peek-at-champions-oncologys-future-earnings
A Peek at Champions Oncology's Future Earn...
12/10/2024 14:02:35

Core News & Articles
Market-Moving News for September 12th
09/12/2024 12:08:39

CSBR: 59% | Champions Oncology shares are trading higher after the company reported better-than-expected Q1 financial results. ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION